HLN:LON
Haleon PLC
GBX 371.00
arrow_downward
-1.01%(-3.80) 1D
Oct 16, 2:06:01 PM GMT+1 · GBX
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HLN...
Open
GBX 369.30
High
GBX 373.40
Low
GBX 369.20
Mkt. cap
32.62B
Avg. vol.
32.44M
Volume
5.28M
Dividend
1.97%
Quarterly dividend
GBX 1.83
Ex-dividend date
Aug 13, 2026
P/E ratio
20.46
52-wk high
GBX 416.10
52-wk low
GBX 317.80
EPS
GBX 0.18
Shares outstanding
8.80B
No. of employees
25K
Open
GBX 369.30
High
GBX 373.40
Low
GBX 369.20
Mkt. cap
32.62B
Avg. vol.
32.44M
Volume
5.28M
Dividend
1.97%
Quarterly dividend
GBX 1.83
Ex-dividend date
Aug 13, 2026
P/E ratio
20.46
52-wk high
GBX 416.10
52-wk low
GBX 317.80
EPS
GBX 0.18
Shares outstanding
8.80B
No. of employees
25K
News stories
From web sources and news partners
ad-hoc-news.de
·
1 day ago
UBS trims Haleon growth forecast to 3.1 percent for Haleon stock
Profile
Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England. It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers, and Centrum vitamins. The company was projected to be a global leader in over the counter medicines with a 7.3 per cent market share in 2022.
Haleon was established on 18 July 2022 as a corporate spin-off from GSK. Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange. Wikipedia
About Haleon PLC